Literature DB >> 9399018

Diabetes-induced alterations in platelet metabolism.

L Mazzanti1, B Mutus.   

Abstract

OBJECTIVES: This review summarizes the recent findings on some aspects of platelet metabolism that appear to be affected as a consequence of diabetes mellitus. The metabolites include glutathione, L-Arginine/nitric oxide, as well as the ATP-dependent exchange of Na+/K+ and Ca2+.
CONCLUSIONS: Several aspects of platelet metabolism are altered in diabetics. These metabolic events give rise to a platelet that has less antioxidants, and higher levels of peroxides. The direct consequence of this is the overproduction platelet agonists. In addition, there is evidence for altered Ca2+ and Na+ transport across the plasma membrane. Recent evidence indicates that plasma ATPases in diabetic platelets are not damaged instead their activities are likely to be modulated by oxidized LDL. Finally, platelet inhibitory mechanisms regulated by NO appear to be perturbed in the diabetes disease-state. The combined production of NO and superoxide by NOS isoforms in the platelet could be a major contributory factor to platelet pathogenesis in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399018     DOI: 10.1016/s0009-9120(97)00094-5

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  The mean platelet volume in gestational diabetes.

Authors:  Nuray Bozkurt; Ercan Yilmaz; Aydan Biri; Zeki Taner; Ozdemir Himmetoğlu
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

2.  N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.

Authors:  A T Treweeke; T J Winterburn; I Mackenzie; F Barrett; C Barr; G F Rushworth; I Dransfield; S M MacRury; I L Megson
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

3.  Enhanced NTPDase and 5'-nucleotidase activities in diabetes mellitus and iron-overload model.

Authors:  Vinícius Ribas Miron; Liliane Bauermann; André Luis Bittencourt Morsch; Rafael Fernandes Zanin; Maísa Corrêa; Adriane Cismoski da Silva; Cínthia Mazzanti; Vera Maria Morsch; Gilberto Ignácio Lunkes; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2006-11-21       Impact factor: 3.842

4.  Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.

Authors:  Kyle R Gibson; Tim J Winterburn; Fiona Barrett; Sushma Sharma; Sandra M MacRury; Ian L Megson
Journal:  Cardiovasc Diabetol       Date:  2011-05-21       Impact factor: 9.951

Review 5.  Antioxidants in Cardiovascular Therapy: Panacea or False Hope?

Authors:  Katarzyna Goszcz; Sherine J Deakin; Garry G Duthie; Derek Stewart; Stephen J Leslie; Ian L Megson
Journal:  Front Cardiovasc Med       Date:  2015-07-06

6.  Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.

Authors:  James J DiNicolantonio; James H O'Keefe; Mark F McCarty
Journal:  Open Heart       Date:  2017-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.